About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Procedure number
- PSUSA/00009159/202303
- Regulatory outcome
- Variation
Documents
Gentamicin (systemic use): List of nationally authorised medicinal products - PSUSA/00009159/202303
English (EN) (176.65 KB - PDF)
Gentamicin (systemic use): CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00009159/202303
English (EN) (124.4 KB - PDF)
български (BG) (122.35 KB - PDF)
español (ES) (78.51 KB - PDF)
čeština (CS) (105.75 KB - PDF)
dansk (DA) (77.22 KB - PDF)
Deutsch (DE) (109.01 KB - PDF)
eesti keel (ET) (101.28 KB - PDF)
ελληνικά (EL) (126.02 KB - PDF)
français (FR) (116.7 KB - PDF)
hrvatski (HR) (121.47 KB - PDF)
íslenska (IS) (82.08 KB - PDF)
italiano (IT) (79.87 KB - PDF)
latviešu valoda (LV) (151.54 KB - PDF)
lietuvių kalba (LT) (142.53 KB - PDF)
magyar (HU) (118.26 KB - PDF)
Malti (MT) (123.74 KB - PDF)
Nederlands (NL) (83.06 KB - PDF)
norsk (NO) (75.08 KB - PDF)
polski (PL) (195.82 KB - PDF)
português (PT) (97.93 KB - PDF)
română (RO) (214.21 KB - PDF)
slovenčina (SK) (113.8 KB - PDF)
slovenščina (SL) (214.06 KB - PDF)
Suomi (FI) (97.88 KB - PDF)
svenska (SV) (93.62 KB - PDF)